Arvada Therapeutics
Aaron Nelson - Director
Adam Cotton - Observer
Cardiovascular
Boston, USA
Arvada Therapeutics is developing large-molecule therapeutics to treat arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).